Simplex Trading »

Enliven Therapeutics shares owned by Simplex Trading

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Simplex Trading from 13F filings

Historical chart of Simplex Trading investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Simplex Trading

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0k 169 17.75
2025-06-30 $3.0k 183 16.39
2025-03-31 $0 50 0.00
2024-06-30 $2.0k 93 21.51

More positions owned by Simplex Trading

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Put Put Option
Tesla Put Put Option
Nvidia Corporation Put Put Option
Tesla Call Call Option
Invesco Qqq Tr Call Call Option
Nvidia Corporation Call Call Option
Ishares Tr Put Put Option
Ishares Tr Call Call Option
Spdr Gold Tr Call Call Option
Apple Put Put Option
Alphabet Call Call Option
Apple Call Call Option
Meta Platforms Call Call Option

View all positions for Simplex Trading

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Commodore Capital
Fairmount Funds Management
BlackRock
VR Adviser
Polar Capital Holdings
Vanguard Group
Henderson Group
Novo A/S
Pictet Asset Management Holding SA
Blackstone Group
Capital Research Global Investors
Citadel Advisors
Vestal Point Capital

View all funds holding Enliven Therapeutics